Consequently, the intrinsic cell-to-cell variation in the EGFR mutation status might be masked by bulk-cell examination and the mutation status of EGFR might be misinterpreted due to the interference from the genetic heterogeneity of the cancer cells. The gene discussed is EGFR; the disease is cancer.